7 insiders reported 12 Form 4 transactions for Kezar Life Sciences, Inc. (KZR) over the past 18 months (most recent 2026-05-11). Recent activity: Kauffman Michael (Director) Sell 6,369 shares, BERGER FRANKLIN M (Director) Sell 89,069 shares, Belsky Marc (Chief Financial Officer) Sell 1,538 shares, Kirk Christopher J. (CEO) Sell 43,134 shares, Fowler John Franklin (Director) Sell 39,390 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | Kauffman Michael | Director | Sell | 6,369 | $0 |
| 2026-05-11 | BERGER FRANKLIN M | Director | Sell | 89,069 | $0 |
| 2026-05-11 | Belsky Marc | Chief Financial Officer | Sell | 1,538 | $0 |
| 2026-05-11 | Kirk Christopher J. | CEO | Sell | 43,134 | $0 |
| 2026-05-11 | Fowler John Franklin | Director | Sell | 39,390 | $0 |
| 2026-05-11 | Schiller Mark C. | Chief Operating Officer | Sell | 2,739 | $0 |
| 2026-05-11 | Chiang Pichi Luo | SVP, Corporate Controller | Sell | 2,711 | $0 |
| 2026-05-11 | Belsky Marc | Chief Financial Officer | Sell | 200 | $0 |
| 2026-05-11 | Fowler John Franklin | Director | Sell | 375 | $0 |
| 2026-05-11 | Fowler John Franklin | Director | Sell | 3,846 | $0 |
| 2025-07-03 | Schiller Mark C. | Chief Operating Officer | Sell | 561 | $2,401 |
| 2025-07-03 | Chiang Pichi Luo | SVP, Corporate Controller | Sell | 264 | $1,130 |
Source: SEC Form 4 filings · as of 2026-05-11